Preventive effect of Clostridium butyricum MIYAIRI against pouchitis in children with ulcerative colitis
- PMID: 39718596
- DOI: 10.1007/s00595-024-02984-x
Preventive effect of Clostridium butyricum MIYAIRI against pouchitis in children with ulcerative colitis
Abstract
Purpose: Pouchitis is a major complication after ileal pouch-anal anastomosis (IPAA) for ulcerative colitis in children (UCc). In this study, we investigated whether the oral administration of Clostridium butyricum MIYAIRI 588 (CBM) can reduce the incidence of pouchitis after IPAA in UCc.
Methods: We reviewed the data for pediatric patients with UC, who underwent IPAA in Mie University Hospital between 2004 and 2022. Data on the presence and type of postoperative probiotic medication and the timing of probiotic initiation, as well as clinical variables, were collected from the patients' medical records.
Results: During the study period, 55 children with UC underwent radical surgery. During the first 5 years after ileostomy closure, 23 (41.8%) patients suffered at least one pouchitis episode. The incidence of acute pouchitis was significantly lower in the CBM group than in the non-CBM group (CBM vs. non-CBM: 10.5% vs. 58.3%, p < 0.01). Furthermore, even among patients who had been taking any probiotics postoperatively, the CBM group had a significantly lower incidence of both acute and chronic pouchitis than the 'other probiotics' group (p < 0.01).
Conclusion: Oral CBM administration after ileostomy closure may be effective in preventing postoperative pouchitis.
Keywords: Clostridium butyricum; Children; Pouchitis; Probiotics; Ulcerative colitis.
© 2024. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd.
Conflict of interest statement
Declarations. Conflict of interest: We have no conflicts of interest to declare for this article.
Similar articles
-
The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis.Surg Today. 2016 Aug;46(8):939-49. doi: 10.1007/s00595-015-1261-9. Epub 2015 Oct 29. Surg Today. 2016. PMID: 26510664 Clinical Trial.
-
Antibiotic Use in the 12 Months Prior to Ileal Pouch-Anal Anastomosis Increases the Risk for Pouchitis.Clin Gastroenterol Hepatol. 2024 Aug;22(8):1678-1686.e8. doi: 10.1016/j.cgh.2024.03.012. Epub 2024 Mar 29. Clin Gastroenterol Hepatol. 2024. PMID: 38556033 Free PMC article.
-
The Natural History After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Population-Based Cohort Study From the United States.Am J Gastroenterol. 2024 Nov 1;119(11):2267-2274. doi: 10.14309/ajg.0000000000002891. Epub 2024 Jun 18. Am J Gastroenterol. 2024. PMID: 38888231
-
Prevalence of pouchitis in both ulcerative colitis and familial adenomatous polyposis: A systematic review and meta-analysis.Colorectal Dis. 2022 Jan;24(1):27-39. doi: 10.1111/codi.15995. Epub 2021 Dec 3. Colorectal Dis. 2022. PMID: 34800326
-
Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis.World J Gastroenterol. 2014 Aug 7;20(29):9665-74. doi: 10.3748/wjg.v20.i29.9665. World J Gastroenterol. 2014. PMID: 25110406 Free PMC article.
References
-
- Coffey JC, Winter DC, Neary P, Murphy A, Redmond HP, Kirwan WO. Quality of life after ileal pouch-anal anastomosis: an evaluation of diet and other factors using the Cleveland Global Quality of Life instrument. Dis Colon Rectum. 2002;45:30–8. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical